Patient-reported outcomes indicate improved physical function for complete responders in phase II/III bladder cancer study

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Patient-Reported Outcomes of participants in the phase II/III QUILT 3.032 study of N-803 plus BCG in BCG-unresponsive non-muscle invasive bladder cancer were published by the peer-reviewed journal Urology Practice. 

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe
Table of Contents

YOU MAY BE INTERESTED IN

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login